Thomas, Sangeeta S. and Kalia, Nitin Pal and Ruf, Marie-Thérèse and Pluschke, Gerd and Pethe, Kevin. (2020) Toward a single dose cure for Buruli ulcer. Antimicrobial agents and chemotherapy, 64 (9). e00727-20.
Full text not available from this repository.
Official URL: https://edoc.unibas.ch/78510/
Downloads: Statistics Overview
Abstract
A single dose of Q203 (Telacebec), a phase 2 clinical candidate for tuberculosis, eradicates; Mycobacterium ulcerans; in a mouse model of Buruli ulcer infection without relapse up to 19 weeks posttreatment. Clinical use of Q203 may dramatically simplify the clinical management of Buruli ulcer, a neglected mycobacterial disease.
Faculties and Departments: | 09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) 09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Department of Medicine (MED) > Diagnostic (Nickel) |
---|---|
UniBasel Contributors: | Ruf, Marie-Therese |
Item Type: | Article, refereed |
Article Subtype: | Research Article |
ISSN: | 0066-4804 |
Note: | Publication type according to Uni Basel Research Database: Journal article |
Identification Number: |
|
Last Modified: | 19 Dec 2022 08:04 |
Deposited On: | 19 Dec 2022 08:04 |
Repository Staff Only: item control page